Top

Published in:

Open Access 01-12-2021 | Endometriosis | Review Article

Medical and surgical interventions to improve the quality of life for endometriosis patients: a systematic review

Authors: Maurizio Nicola D’Alterio, Stefania Saponara, Mirian Agus, Antonio Simone Laganà, Marco Noventa, Emanuela Stochino Loi, Anis Feki, Stefano Angioni

Published in: Gynecological Surgery | Issue 1/2021

Abstract

Endometriosis impairs the quality of life (QoL) of many women, including their social relationships, daily activity, productivity at work, and family planning. The aim of this review was to determine the instruments used to examine QoL in previous clinical studies of endometriosis and to evaluate the effect of medical and surgical interventions for endometriosis on QoL. We conducted a systematic search and review of studies published between January 2010 and December 2020 using MEDLINE. Search terms included “endometriosis” and “quality of life.” We only selected studies that used a standardized questionnaire to evaluate QoL before and after medical or surgical interventions. Only articles in the English language were examined. The initial search identified 720 results. After excluding duplicates and applying inclusion criteria, 37 studies were selected for analysis. We found that the two scales most frequently used to measure QoL were the Short Form-36 health survey questionnaire (SF-36) and the Endometriosis Health Profile-30 (EHP-30). Many medical and surgical treatments demonstrated comparable benefits in pain control and QoL improvement. There is no clear answer as to what is the best treatment for improving QoL because each therapy must be personalized for the patient and depends on the woman’s goals. In conclusion, women must be informed about endometriosis and given easily accessible information to improve treatment adherence and their QoL.

Angioni S (2017) New insights on endometriosis. Minerva Ginecol 69(5):438–439. https://doi.org/10.23736/S0026-4784.17.04089-8CrossRefPubMed

Pontis A, Arena I, Angioni S (2014) Umbilical endometriosis primary site without pelvic endometriosis and previous surgery: a case report. G Ital di Ostet e Ginecol 36:336–338. https://doi.org/10.11138/giog/2014.36.2.336CrossRef

Eisenberg VH, Weil C, Chodick G, Shalev V (2018) Epidemiology of endometriosis: a large population-based database study from a healthcare provider with 2 million members. BJOG An Int J Obstet Gynaecol 125(1):55–62. https://doi.org/10.1111/1471-0528.14711CrossRef

Stochino-Loi E, Millochau J-C, Angioni S et al (2020) Relationship between patient age and disease features in a prospective cohort of 1560 women affected by endometriosis. J Minim Invasive Gynecol 27(5):1158–1166. https://doi.org/10.1016/j.jmig.2019.09.004CrossRefPubMed

Melis I, Agus M, Pluchino N et al (2014) Alexithymia in women with deep endometriosis? A pilot study. J Endometr 6(1):26–33. https://doi.org/10.5301/je.5000172CrossRef

Melis I, Litta P, Nappi L et al (2015) Sexual function in women with deep endometriosis: correlation with quality of life, intensity of pain, depression, anxiety, and body image. Int J Sex Health 27. https://doi.org/10.1080/19317611.2014.952394

Angioni S, Cela V, Sedda F et al (2015) Focusing on surgery results in infertile patients with deep endometriosis. Gynecol Endocrinol 31(8):595–598. https://doi.org/10.3109/09513590.2015.1062868CrossRefPubMed

Alio L, Angioni S, Arena S et al (2019) Endometriosis: seeking optimal management in women approaching menopause. Climacteric 22(4):329–338. https://doi.org/10.1080/13697137.2018.1549213CrossRefPubMed

Stochino-Loi E, Darwish B, Mircea O et al (2017) Does preoperative antimüllerian hormone level influence postoperative pregnancy rate in women undergoing surgery for severe endometriosis? Fertil Steril 107(3):707–713.e3. https://doi.org/10.1016/j.fertnstert.2016.12.013CrossRefPubMed

10.

Deiana D, Gessa S, Anardu M et al (2019) Genetics of endometriosis: a comprehensive review. Gynecol Endocrinol 35:553–558. https://doi.org/10.1080/09513590.2019.1588244CrossRefPubMed

11.

Angioni S, D’alterio MN, Coiana A et al (2020) Genetic characterization of endometriosis patients: review of the literature and a prospective cohort study on a mediterranean population. Int J Mol Sci 21(5). https://doi.org/10.3390/ijms21051765

12.

Viganó D, Zara F, Pinto S et al (2020) How is small bowel permeability in endometriosis patients? A case control pilot study. Gynecol Endocrinol 36(11):1010–1014. https://doi.org/10.1080/09513590.2020.1766440CrossRefPubMed

13.

Murgia F, Angioni S, D’Alterio MN et al (2021) Metabolic profile of patients with severe endometriosis: a prospective experimental study. Reprod Sci 28(3):728–735. https://doi.org/10.1007/s43032-020-00370-9CrossRefPubMed

14.

Triolo O, Laganà AS, Sturlese E (2013) Chronic pelvic pain in endometriosis: an overview. J Clin Med Res 5(3):153–163. https://doi.org/10.4021/jocmr1288wCrossRefPubMedPubMedCentral

15.

Angioni S, Cofelice V, Sedda F et al (2015) Progestins for symptomatic endometriosis: results of clinical studies. Curr Drug Ther 10(2):91–104. https://doi.org/10.2174/157488551002151222160051CrossRef

16.

Jia SZ, Leng JH, Shi JH et al (2012) Health-related quality of life in women with endometriosis: a systematic review. J Ovarian Res 5(1). https://doi.org/10.1186/1757-2215-5-29

17.

Vitale SG, La Rosa VL, Rapisarda AMC, Laganà AS (2017) Impact of endometriosis on quality of life and psychological well-being. J Psychosom Obstet Gynecol 38(4):317–319. https://doi.org/10.1080/0167482X.2016.1244185CrossRef

18.

D’Alterio MN, D’Ancona G, Raslan M et al (2020) Management challenges of deep infiltrating endometriosis. Int J Fertil Steril. https://doi.org/10.22074/ijfs.2020.134689

19.

Vignali M, Belloni GM, Pietropaolo G et al (2020) Effect of dienogest therapy on the size of the endometrioma. Gynecol Endocrinol. https://doi.org/10.1080/09513590.2020.1725965

20.

Angioni S, Pontis A, Malune ME et al (2020) Is dienogest the best medical treatment for ovarian endometriomas? Results of a multicentric case control study. Gynecol Endocrinol 36(1):84–86. https://doi.org/10.1080/09513590.2019.1640674CrossRefPubMed

21.

Melis GB, Neri M, Corda V et al (2016) Overview of elagolix for the treatment of endometriosis. Expert Opin Drug Metab Toxicol 12(5):581–588. https://doi.org/10.1517/17425255.2016.1171316CrossRefPubMed

22.

Alessandro P, Luigi N, Felice S et al (2017) Research development of a new GnRH antagonist (Elagolix) for the treatment of endometriosis: a review of the literature. Arch Gynecol Obstet 295(4):827–832. https://doi.org/10.1007/s00404-017-4328-6CrossRefPubMed

23.

Parazzini F, Viganò P, Candiani M, Fedele L (2013) Diet and endometriosis risk: a literature review. Reprod BioMed Online 26(4):323–336. https://doi.org/10.1016/j.rbmo.2012.12.011CrossRefPubMed

24.

Stochino-Loi E, Pontis A, Cofelice V et al (2019) Effect of ultramicronized-palmitoylethanolamide and co-micronizedpalmitoylethanolamide/polydatin on chronic pelvic pain and quality of life in endometriosis patients: an open-label pilot study. Int J Women's Health 11:443–449. https://doi.org/10.2147/IJWH.S204275CrossRef

25.

Endometriosis Treatment Italian Club (ETIC) (2019, 2019) When more is not better: 10 “Don’ts” in endometriosis management. An ETIC position statement. Hum Reprod Open (3):hoz009. https://doi.org/10.1093/HROPEN/HOZ009

26.

Angioni S, Pontis A, Cela V et al (2015) Surgical technique of endometrioma excision impacts on the ovarian reserve. Single-port access laparoscopy versus multiport access laparoscopy: a case control study. Gynecol Endocrinol 31(6):454–457. https://doi.org/10.3109/09513590.2015.1017812CrossRefPubMed

27.

Nappi L, Angioni S, Sorrentino F et al (2016) Anti-Mullerian hormone trend evaluation after laparoscopic surgery of monolateral endometrioma using a new dual wavelengths laser system (DWLS) for hemostasis. Gynecol Endocrinol 32(1):34–37. https://doi.org/10.3109/09513590.2015.1068754CrossRefPubMed

28.

The WHOQOL Group (1993) Study protocol for the World Health Organization project to develop a quality of life assessment instrument (WHOQOL). Qual Life Res 2(2):153–159. https://doi.org/10.1007/BF00435734CrossRef

29.

Cagnacci A, Della Vecchia E, Xholli A (2019) Chronic pelvic pain improvement: impact on quality of life and mood. Gynecol Endocrinol 35(6):502–505. https://doi.org/10.1080/09513590.2018.1540571CrossRefPubMed

30.

Eriksen HLF, Gunnersen KF, Sørensen JA et al (2008) Psychological aspects of endometriosis: differences between patients with or without pain on four psychological variables. Eur J Obstet Gynecol Reprod Biol 139(1):100–105. https://doi.org/10.1016/j.ejogrb.2007.10.002CrossRefPubMed

31.

Tripoli TM, Sato H, Sartori MG et al (2011) Evaluation of quality of life and sexual satisfaction in women suffering from chronic pelvic pain with or without endometriosis. J Sex Med 8(2):497–503. https://doi.org/10.1111/j.1743-6109.2010.01976.xCrossRefPubMed

32.

Denny E (2009) “I never know from one day to another how I will feel”: pain and uncertainty in women with endometriosis. Qual Health Res 19(7):985–995. https://doi.org/10.1177/1049732309338725CrossRefPubMed

33.

Facchin F, Barbara G, Saita E et al (2015) Impact of endometriosis on quality of life and mental health: pelvic pain makes the difference. J Psychosom Obstet Gynecol 36(4):135–141. https://doi.org/10.3109/0167482X.2015.1074173CrossRef

34.

Gao X, Yeh YC, Outley J et al (2006) Health-related quality of life burden of women with endometriosis: a literature review. Curr Med Res Opin 22(9):1787–1797. https://doi.org/10.1185/030079906X121084CrossRefPubMed

35.

Marinho MCP, Magalhaes TF, Fernandes LFC et al (2018) Quality of life in women with endometriosis: an integrative review. J Women's Health 27(3):399–408. https://doi.org/10.1089/jwh.2017.6397CrossRef

36.

Bourdel N, Chauvet P, Billone V et al (2019) Systematic review of quality of life measures in patients with endometriosis. PLoS One 14(1):e0208464. https://doi.org/10.1371/journal.pone.0208464CrossRefPubMedPubMedCentral

37.

Ware JEJ, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30(6):473–483CrossRef

38.

Stull DE, Wasiak R, Kreif N et al (2014) Validation of the SF-36 in patients with endometriosis. Qual Life Res 23(1):103–117. https://doi.org/10.1007/s11136-013-0442-5CrossRefPubMed

39.

Gandek B, Ware JE, Aaronson NK et al (1998) Cross-validation of item selection and scoring for the SF-12 health survey in nine countries: results from the IQOLA project. J Clin Epidemiol 51(11):1171–1178. https://doi.org/10.1016/S0895-4356(98)00109-7CrossRefPubMed

40.

Jones G, Jenkinson C, Kennedy S (2004) Evaluating the responsiveness of the endometriosis health profile questionnaire: the EHP-30. Qual Life Res 13(3):705–713. https://doi.org/10.1023/B:QURE.0000021316.79349.afCrossRefPubMed

41.

Jones G, Jenkinson C, Kennedy S (2004) Development of the short form endometriosis health profile questionnaire: the EHP-5. Qual Life Res 13(3):695–704. https://doi.org/10.1023/B:QURE.0000021321.48041.0eCrossRefPubMed

42.

Skevington SM, Bradshaw J, Saxena S (1999) Selecting national items for the WHOQOL: conceptual and psychometric considerations. Soc Sci Med 48(4):473–487. https://doi.org/10.1016/S0277-9536(98)00355-4CrossRefPubMed

43.

Skevington SM, Carse MS, De C, Williams AC (2001) Validation of the WHOQOL-100: pain management improves quality of life for chronic pain patients. Clin J Pain 17(3):264–275. https://doi.org/10.1097/00002508-200109000-00013CrossRefPubMed

44.

Balestroni G, Bertolotti G (2012) EuroQol-5D (EQ-5D): an instrument for measuring quality of life. Monaldi Arch Chest Dis - Card Ser 78(3):155–159. https://doi.org/10.4081/monaldi.2012.121CrossRef

45.

Moher D, Shamseer L, Clarke M et al (2016) Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Rev Esp Nutr Humana y Diet 20(2):148–160. https://doi.org/10.1186/2046-4053-4-1CrossRef

46.

Zhao L, Wu H, Zhou X et al (2012) Effects of progressive muscular relaxation training on anxiety, depression and quality of life of endometriosis patients under gonadotrophin-releasing hormone agonist therapy. Eur J Obstet Gynecol Reprod Biol 162(2):211–215. https://doi.org/10.1016/j.ejogrb.2012.02.029CrossRefPubMed

47.

Agarwal SK, Daniels A, Drosman SR et al (2015) Treatment of endometriosis with the GnRHa deslorelin and add-back estradiol and supplementary testosterone. Biomed Res Int 2015. https://doi.org/10.1155/2015/934164

48.

Lee DY, Lee JY, Seo JW et al (2016) Gonadotropin-releasing hormone agonist with add–back treatment is as effective and tolerable as dienogest in preventing pain recurrence after laparoscopic surgery for endometriosis. Arch Gynecol Obstet 294(6):1257–1263. https://doi.org/10.1007/s00404-016-4184-9CrossRefPubMed

49.

Granese R, Perino A, Calagna G et al (2015) Gonadotrophin-releasing hormone analogue or dienogest plus estradiol valerate to prevent pain recurrence after laparoscopic surgery for endometriosis: a multi-center randomized trial. Acta Obstet Gynecol Scand 94(6):637–645. https://doi.org/10.1111/aogs.12633CrossRefPubMed

50.

Ács N, O’Brien C, Jiang P et al (2015) Treatment of endometriosis-associated pain with elagolix, an oral GnRH antagonist: results from a phase 2, randomized controlled study. J Endometr Pelvic Pain Disord 7(2):56–62. https://doi.org/10.5301/je.5000211CrossRef

51.

Caruso S, Iraci M, Cianci S et al (2015) Quality of life and sexual function of women affected by endometriosis-associated pelvic pain when treated with dienogest. J Endocrinol Investig 38(11):1211–1218. https://doi.org/10.1007/s40618-015-0383-7CrossRef

52.

Luisi S, Parazzini F, Angioni S et al (2015) Dienogest treatment improves quality of life in women with endometriosis. J Endometr 7(4):124–128. https://doi.org/10.5301/je.5000232CrossRef

53.

Strowitzki T, Faustmann T, Gerlinger C, Seitz C (2010) Dienogest in the treatment of endometriosis-associated pelvic pain: a 12-week, randomized, double-blind, placebo-controlled study. Eur J Obstet Gynecol Reprod Biol 151(2):193–198. https://doi.org/10.1016/j.ejogrb.2010.04.002CrossRefPubMed

54.

Strowitzki T, Marr J, Gerlinger C et al (2010) Dienogest is as effective as leuprolide acetate in treating the painful symptoms of endometriosis: a 24-week, randomized, multicentre, open-label trial. Hum Reprod 25(3):633–641. https://doi.org/10.1093/humrep/dep469CrossRefPubMed

55.

Leonardo-Pinto JP, Benetti-Pinto CL, Cursino K, Yela DA (2017) Dienogest and deep infiltrating endometriosis: the remission of symptoms is not related to endometriosis nodule remission. Eur J Obstet Gynecol Reprod Biol 211:108–111. https://doi.org/10.1016/j.ejogrb.2017.02.015CrossRefPubMed

56.

Seo JW, Lee DY, Kim SE et al (2019) Comparison of long-term use of combined oral contraceptive after gonadotropin-releasing hormone agonist plus add-back therapy versus dienogest to prevent recurrence of ovarian endometrioma after surgery. Eur J Obstet Gynecol Reprod Biol 236:53–57. https://doi.org/10.1016/j.ejogrb.2019.02.032CrossRefPubMed

57.

Caruso S, Iraci M, Cianci S et al (2016) Comparative, open-label prospective study on the quality of life and sexual function of women affected by endometriosis-associated pelvic pain on 2 mg dienogest/30 μg ethinyl estradiol continuous or 21/7 regimen oral contraceptive. J Endocrinol Investig 39(8):923–931. https://doi.org/10.1007/s40618-016-0460-6CrossRef

58.

Morotti M, Remorgida V, Venturini PL, Ferrero S (2014) Progestogen-only contraceptive pill compared with combined oral contraceptive in the treatment of pain symptoms caused by endometriosis in patients with migraine without aura. Eur J Obstet Gynecol Reprod Biol 179:63–68. https://doi.org/10.1016/j.ejogrb.2014.05.016CrossRefPubMed

59.

Tanmahasamut P, Rattanachaiyanont M, Angsuwathana S et al (2012) Postoperative levonorgestrel-releasing intrauterine system for pelvic endometriosis-related pain: a randomized controlled trial. Obstet Gynecol 119(3):519–526. https://doi.org/10.1097/AOG.0b013e31824264c3CrossRefPubMed

60.

Yucel N, Baskent E, Karamustafaoglu Balci B, Goynumer G (2018) The levonorgestrel-releasing intrauterine system is associated with a reduction in dysmenorrhoea and dyspareunia, a decrease in CA 125 levels, and an increase in quality of life in women with suspected endometriosis. Aust New Zeal J Obstet Gynaecol 58(5):560–563. https://doi.org/10.1111/ajo.12773CrossRef

61.

Sansone A, De Rosa N, Giampaolino P et al (2018) Effects of etonogestrel implant on quality of life, sexual function, and pelvic pain in women suffering from endometriosis: results from a multicenter, prospective, observational study. Arch Gynecol Obstet 298(4). https://doi.org/10.1007/s00404-018-4851-0

62.

Carvalho N, Margatho D, Cursino K et al (2018) Control of endometriosis-associated pain with etonogestrel-releasing contraceptive implant and 52-mg levonorgestrel-releasing intrauterine system: randomized clinical trial. Fertil Steril 110(6):1129–1136. https://doi.org/10.1016/j.fertnstert.2018.07.003CrossRefPubMed

63.

Caruso S, Iraci Sareri M, Casella E et al (2015) Chronic pelvic pain, quality of life and sexual health of women treated with palmitoylethanolamide and α-lipoic acid. Minerva Ginecol 67(5):413–419PubMed

64.

Deguara CS, Liu B, Davis C (2013) Measured symptomatic and psychological outcomes in women undergoing laparoscopic surgery for endometriosis: a prospective study. Curr Opin Obstet Gynecol 25(4):299–301. https://doi.org/10.1097/GCO.0b013e3283630da7CrossRefPubMed

65.

Comptour A, Chauvet P, Canis M et al (2019) Patient quality of life and symptoms after surgical treatment for endometriosis. J Minim Invasive Gynecol 26(4):717–726. https://doi.org/10.1016/j.jmig.2018.08.005CrossRefPubMed

66.

Valentin L, Canis M, Pouly JL et al (2017) SF-36 preoperative interest of predicting improvement of quality of life after laparoscopic management of minimal endometriosis. J Gynecol Obstet Hum Reprod 46(2):137–142. https://doi.org/10.1016/j.jogoh.2016.12.004CrossRefPubMed

67.

Mabrouk M, Montanari G, Guerrini M et al (2011) Does laparoscopic management of deep infiltrating endometriosis improve quality of life? A prospective study. Health Qual Life Outcomes 9:98. https://doi.org/10.1186/1477-7525-9-98CrossRefPubMedPubMedCentral

68.

Bassi MA, Podgaec S, Dias JA et al (2011) Quality of life after segmental resection of the rectosigmoid by laparoscopy in patients with deep infiltrating endometriosis with bowel involvement. J Minim Invasive Gynecol 18(6):730–733. https://doi.org/10.1016/j.jmig.2011.07.014CrossRefPubMed

69.

Silveira da Cunha Araújo R, Abdalla Ayroza Ribeiro HS, Sekula VG et al (2014) Long-term outcomes on quality of life in women submitted to laparoscopic treatment for bowel endometriosis. J Minim Invasive Gynecol 21(4):682–688. https://doi.org/10.1016/j.jmig.2014.02.005CrossRefPubMed

70.

Riiskjær M, Forman A, Kesmodel US et al (2018) Pelvic pain and quality of life before and after laparoscopic bowel resection for rectosigmoid endometriosis: a prospective, observational study. Dis Colon Rectum 61(2):221–229. https://doi.org/10.1097/DCR.0000000000000970CrossRefPubMed

71.

Byrne D, Curnow T, Smith P et al (2018) Laparoscopic excision of deep rectovaginal endometriosis in BSGE endometriosis centres: a multicentre prospective cohort study. BMJ Open 8(4). https://doi.org/10.1136/bmjopen-2017-018924

72.

Roman H, Bubenheim M, Huet E et al (2018) Conservative surgery versus colorectal resection in deep endometriosis infiltrating the rectum: a randomized trial. Hum Reprod 33(1):47–57. https://doi.org/10.1093/humrep/dex336CrossRefPubMed

73.

Roman H, Tuech JJ, Huet E et al (2019) Excision versus colorectal resection in deep endometriosis infiltrating the rectum: 5-year follow-up of patients enrolled in a randomized controlled trial. Hum Reprod 34(12):2362–2671. https://doi.org/10.1093/humrep/dez217CrossRefPubMedPubMedCentral

74.

Ribeiro PAA, Sekula VG, Abdalla-Ribeiro HS et al (2014) Impact of laparoscopic colorectal segment resection on quality of life in women with deep endometriosis: one year follow-up. Qual Life Res 23(2):641–645. https://doi.org/10.1007/s11136-013-0481-yCrossRef

75.

Daraï E, Dubernard G, Coutant C et al (2010) Randomized trial of laparoscopically assisted versus open colorectal resection for endometriosis: morbidity, symptoms, quality of life, and fertility. Ann Surg 251(6):1018–1023. https://doi.org/10.1097/SLA.0b013e3181d9691dCrossRefPubMed

76.

Touboul C, Ballester M, Dubernard G et al (2015) Long-term symptoms, quality of life, and fertility after colorectal resection for endometriosis: extended analysis of a randomized controlled trial comparing laparoscopically assisted to open surgery. Surg Endosc 29(7):1879–1887. https://doi.org/10.1007/s00464-014-3880-4CrossRefPubMed

77.

Kent A, Shakir F, Rockall T et al (2016) Laparoscopic surgery for severe rectovaginal endometriosis compromising the bowel: a prospective cohort study. J Minim Invasive Gynecol 23(4):526–534. https://doi.org/10.1016/j.jmig.2015.12.006CrossRefPubMed

78.

Angioni S, Pontis A, Dessole M et al (2015) Pain control and quality of life after laparoscopic en-block resection of deep infiltrating endometriosis (DIE) vs. incomplete surgical treatment with or without GnRHa administration after surgery. Arch Gynecol Obstet 291(2):363–370. https://doi.org/10.1007/s00404-014-3411-5CrossRefPubMed

79.

Meuleman C, Tomassetti C, Wolthuis A et al (2014) Clinical outcome after radical excision of moderate-severe endometriosis with or without bowel resection and reanastomosis: a prospective cohort study. In: Annals of surgery. Ann Surg, pp 522–531

80.

Misra G, Sim J, El-Gizawy Z et al (2020) Laparoscopic ablation or excision with helium thermal coagulator versus electrodiathermy for the treatment of mild-to-moderate endometriosis: randomised controlled trial. BJOG An Int J Obstet Gynaecol 127(12):1528–1535. https://doi.org/10.1111/1471-0528.16279CrossRef

81.

Soto E, Luu TH, Liu X et al (2017) Laparoscopy vs. robotic surgery for endometriosis (LAROSE): a multicenter, randomized, controlled trial. In: Fertility and sterility. Elsevier Inc., pp 996–1002.e3

82.

Pontis A, Nappi L, Sedda F et al (2016) Management of bladder endometriosis with combined transurethral and laparoscopic approach. Follow-up of pain control, quality of life, and sexual function at 12 months after surgery. Clin Exp Obstet Gynecol 43(6):836–839. https://doi.org/10.12891/ceog3367.2016CrossRefPubMed

83.

Canis M, Donnez JG, Guzick DS et al (1997) Revised American Society for Reproductive Medicine classification of endometriosis: 1996. Fertil Steril 67(5):817–821. https://doi.org/10.1016/S0015-0282(97)81391-XCrossRef

84.

Wium-Andersen MK, Ørsted DD, Nielsen SF, Nordestgaard BG (2013) Elevated C-reactive protein levels, psychological distress, and depression in 73131 individuals. JAMA Psychiatry 70(2):176–184. https://doi.org/10.1001/2013.jamapsychiatry.102CrossRefPubMed

85.

Nasyrova RF, Sotnikova LS, Baystrukova NV et al (2011) Psychoimmune interactions in women of reproductive age with endometriosis. Bull Exp Biol Med 152(1):93–97. https://doi.org/10.1007/s10517-011-1463-0CrossRefPubMed

86.

Stratton P, Berkley KJ (2011) Chronic pelvic pain and endometriosis: translational evidence of the relationship and implications. Hum Reprod Update 17(3):327–346. https://doi.org/10.1093/humupd/dmq050CrossRefPubMed

87.

Vincent K, Kennedy S, Stratton P (2010) Pain scoring in endometriosis: entry criteria and outcome measures for clinical trials. Report from the art and science of endometriosis meeting. Fertil Steril 93(1):62–67. https://doi.org/10.1016/j.fertnstert.2008.09.056CrossRefPubMed

88.

Kho RM, Andres MP, Borrelli GM, Neto JS, Zanluchi A, Abrão MS (2018) Surgical treatment of different types of endometriosis: comparison of major society guidelines and preferred clinical algorithms. Best Pract Res Clin Obstet Gynaecol 51:102–110. https://doi.org/10.1016/j.bpobgyn.2018.01.020CrossRefPubMed

89.

Leyland N, Casper R, Laberge P, Singh SS, Society of Obstetricians and Gynaecologists of Canada (SOGC) (2010) Endometriosis: diagnosis and management. J Obstet Gynaecol Can 32:S1–S3CrossRef

90.

Vercellini P, Viganò P, Buggio L, Somigliana E (2018) “We can work it out:” the hundred years’ war between experts of surgical and medical treatment for symptomatic deep endometriosis. J Minim Invasive Gynecol 25:356–359. https://doi.org/10.1016/j.jmig.2017.09.026CrossRefPubMed

91.

Laganà AS, La Rosa VL (2020) Multidisciplinary management of endometriosis: current strategies and future challenges. Minerva Med 111:18–20. https://doi.org/10.23736/s0026-4806.19.06370-5CrossRefPubMed

Title: Medical and surgical interventions to improve the quality of life for endometriosis patients: a systematic review
Authors: Maurizio Nicola D’Alterio
Stefania Saponara
Mirian Agus
Antonio Simone Laganà
Marco Noventa
Emanuela Stochino Loi
Anis Feki
Stefano Angioni
Publication date: 01-12-2021
Publisher: Springer Berlin Heidelberg
Keywords: Endometriosis
Dienogest
Published in: Gynecological Surgery / Issue 1/2021
Print ISSN: 1613-2076
Electronic ISSN: 1613-2084
DOI: https://doi.org/10.1186/s10397-021-01096-5

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Medical and surgical interventions to improve the quality of life for endometriosis patients: a systematic review

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2021

The development and psychometric validation of a low-cost anthropomorphic 3D-printout simulator for training basic skills applicable to office-based hysteroscopy

Indocyanine green fluorescence imaging, sentinel lymph node mapping in patients with vulvar cancer: peritumoral injection dosage and waiting times in our experience

Femoral nerve injury in gynecologic surgery: medico-legal issues for best surgical practices

Laparoscopic uterosacral ligament suspension versus sacrospinous ligament fixation for apical prolapse: perioperative outcomes

Laparoscopy approach to sigmoid colon perforation secondary to intrauterine device migration

Prediction of unsuccessful endometrial ablation: random forest vs logistic regression